期刊文献+

不同大脑半球胶质瘤术后功能障碍状况统计分析

Analysis of functional outcomes with gliomas in different hemisphere
下载PDF
导出
摘要 目的 分析不同大脑半球胶质瘤患者手术前后功能障碍情况,为临床治疗提供依据. 方法 收集神经外科住院手术治疗、有完整病案记录和随访记录的158例单侧大脑半球胶质瘤患者的资料.用KPS评分来对比2组患者随访6个月及12个月的功能状况. 结果 2组患者手术切除程度、手术后并发症、随访6个月及12个月的功能状况没有差别. 结论 优势半球与非优势半球胶质瘤手术后功能障碍相比没有差异,肿瘤位置不能作为肿瘤切除程度及术后功能障碍的判断因素. Objective To analyze functional outcomes in patients with gliomas in different hemisphere, and to provide objective references for clinical treatment. Methods Data of 158 patients with cerebral hemisphere gliomas,treated surgically in the department of neurosurgery. KPS was used to compare the functional outcomes in 6 months and 12 months. Results The extent of tumor resection, postoperative complications, functional outcomes in 6 months and 12 months in the patients of two cohorts were no statistically significant. Conclusion There is no difference in postoperative functional outcomes between the patients with gliomas in different hemisphere, suggesting that lesions in DH and NDH is not related to tumor resection and prognosis.
出处 《中国医院统计》 2010年第3期209-211,共3页 Chinese Journal of Hospital Statistics
基金 江苏省中青年科技领军人才基金项目(200716)
关键词 胶质瘤 功能障碍 统计分析 Glioma Functional outcomes Statistical analysis
  • 相关文献

参考文献4

  • 1陈忠平.脑胶质瘤的综合治疗[M].广州:科学教育出版社,2004:38-39.
  • 2Lacroix M,Abi-Said D,Fourney DR,et a1.A multivariate analysis of 416 patients with glioblastoma muhiforme:prognosis,extent of resection and surviva1[J].Neurosurgery,2001,95(2):190-195.
  • 3Polin RS,Marko NF,Ammerman MD,et a1.Functional outcomes and survival in patients with high-grade glioma in dominant and nondominant hemispheres[J].Neurosurgery,2005,102(2):276-279.
  • 4周旺宁,陈忠平,游潮,牟永告,赛克,张俊英,张湘衡,程金建,徐红超.星形细胞瘤的个体化治疗:显微手术、放疗、化疗及其疗效[J].癌症,2004,23(z1):1555-1560. 被引量:15

二级参考文献13

  • 1[2]Macdonald DR. New frontiers in the treatment of malignant gliomas [J]. Semin Oncol, 2003, 30(6suppl 19): 72-76.
  • 2[3]Hentschel S J, Lang FF. Current surgical management of glioblastoma [J]. Cancer J, 2003, 9(2): 113- 125.
  • 3[4]Youmans JR. Neurological Surgery [M]. Philadelphia: WB Saunders Company, 1996:2521 - 2522.
  • 4[5]Grossman RG, Loftus CM. Primary intrinsic tumors of the brain [M]. Princinples of Neurosurgery, Second edition, Philadephia,1999, 474 - 483.
  • 5[6]Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas [J]. J Neurooncol, 1999,42(3):227-231.
  • 6[7]Davis F, Freels S, Grutsch J, et al. Survival rates in patients with primary malignant brain tumors straitified by patient age and tumor histological type: an analysis based on Surveillance,Epidemiology, and End Result (SEER) data, 1973-1991 [J]. J Neurosurgery, 1998, 88(1): 1-10.
  • 7[8]Schmidinger M, Linzmayer L, Becherer A, et al. Psychometric and quality-of-life assessment in long-term glioblastoma survivors [J].J Neurooncol, 2003, 63 ( 1 ): 55 - 61.
  • 8[9]Chang SM, Parney IF, McDermott M, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project [J]. J Neurosurg, 2003 98(6): 1175 - 1181.
  • 9[10]Botturi M, Fariselli L. Clinical results of unconventional fractionation radiotherapy in central nervous system tumors [J].Tumori, 1998, 84(2): 176 - 187.
  • 10[11]Glioma Meta-Analysis Trialists (GMT) Group. Chemotherapy for high-grade glioma[J]. Cochrane Database Syst Rev, 2002, (4):CD003913.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部